FDA Clearance Tracker · K212399
Aveli
Last checked: Nov 20, 2026Latest source record: Oct 22, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 22, 2021
Substantially Equivalent
Time to decision
81 days
Received Aug 2, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K212399
- Device name
- Aveli
- Applicant
- Nc8, Inc.
- Applicant location
- Mountain View, CA
- Received
- Aug 2, 2021
- Decided
- Oct 22, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.4790
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OUP. The earliest in FDA's data is DEN110004, decided Jul 12, 2013.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K212399
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Nc8, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.